Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The case for neo-adjuvant chemotherapy. For.

Literature DB >> 18777621

The case for neo-adjuvant chemotherapy. For.

Hassan Z Malik¹.

Abstract

Mesh：

Substances：
Antineoplastic Agents

Year: 2008 PMID： 18777621 PMCID： PMC2647234 DOI： 10.1308/003588408X321620

Source DB: PubMed Journal: Ann R Coll Surg Engl ISSN： 0035-8843 Impact factor: 1.891

Keyword Cloud
References

× No keyword cloud information.

24 in total

1. Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma.

Authors: G Folprecht; M P Lutz; P Schöffski; T Seufferlein; A Nolting; P Pollert; C-H Köhne
Journal: Ann Oncol Date: 2005-11-22 Impact factor: 32.976

2. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

Authors: Jean-Nicolas Vauthey; Timothy M Pawlik; Dario Ribero; Tsung-Teh Wu; Daria Zorzi; Paulo M Hoff; Henry Q Xiong; Cathy Eng; Gregory Y Lauwers; Mari Mino-Kenudson; Mauro Risio; Andrea Muratore; Lorenzo Capussotti; Steven A Curley; Eddie K Abdalla
Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544

3. Global cancer statistics, 2002.

Authors: D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal: CA Cancer J Clin Date: 2005 Mar-Apr Impact factor: 508.702

4. Solitary colorectal liver metastasis: resection determines outcome.

Authors: Thomas A Aloia; Jean-Nicolas Vauthey; Evelyne M Loyer; Dario Ribero; Timothy M Pawlik; Steven H Wei; Steven A Curley; Daria Zorzi; Eddie K Abdalla
Journal: Arch Surg Date: 2006-05

5. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.

Authors: Nancy Kemeny; Ahmed Eid; Jennifer Stockman; Mithat Gonen; Lawrence Schwartz; Eric Tetzlaff; Philip Paty
Journal: J Surg Oncol Date: 2005-08-01 Impact factor: 3.454

6. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.

Authors: G Folprecht; A Grothey; S Alberts; H-R Raab; C-H Köhne
Journal: Ann Oncol Date: 2005-05-03 Impact factor: 32.976

The case for neo-adjuvant chemotherapy. For.

1. Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma.

2. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

3. Global cancer statistics, 2002.

4. Solitary colorectal liver metastasis: resection determines outcome.

5. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.

6. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.

7. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.

Review 8. Management strategies for colorectal liver metastases--Part I.

9. Factors influencing the natural history of colorectal liver metastases.

Review 10. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies.